MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 94 filers reported holding MENLO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,536,000 | -40.2% | 887,959 | -7.4% | 0.00% | -100.0% |
| Q1 2020 | $2,569,000 | +2323.6% | 958,686 | +4061.7% | 0.00% | – |
| Q4 2019 | $106,000 | +241.9% | 23,036 | +231.4% | 0.00% | – |
| Q3 2019 | $31,000 | +933.3% | 6,952 | +1276.6% | 0.00% | – |
| Q2 2019 | $3,000 | -98.9% | 505 | -98.6% | 0.00% | – |
| Q1 2019 | $280,000 | -24.5% | 35,621 | -60.4% | 0.00% | – |
| Q4 2018 | $371,000 | -45.2% | 90,050 | +31.0% | 0.00% | – |
| Q3 2018 | $677,000 | +509.9% | 68,753 | +401.3% | 0.00% | – |
| Q2 2018 | $111,000 | -79.4% | 13,715 | -4.5% | 0.00% | – |
| Q1 2018 | $540,000 | – | 14,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners L.P. | 1,461,552 | $11,868,000 | 12.24% |
| Vivo Capital, LLC | 4,011,236 | $32,571,000 | 4.20% |
| DAFNA Capital Management LLC | 312,000 | $2,533,000 | 1.19% |
| Novo Holdings A/S | 1,436,313 | $11,663,000 | 1.17% |
| Perceptive Advisors | 1,241,287 | $10,079,000 | 0.26% |
| Rock Springs Capital Management LP | 330,000 | $2,680,000 | 0.10% |
| Baker Brothers Advisors | 700,000 | $5,684,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 50,000 | $406,000 | 0.02% |
| A.R.T. Advisors, LLC | 31,703 | $257,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 2,036,111 | $16,533,000 | 0.01% |